MedTrace Logo

Performance of Junctional Tourniquets in Normal Human Volunteers

NCT01965561 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-12-13

Study results available
· View outcomes & findings →

Summary

Normal human adult volunteers wereused to investigate the performance of medical devices intended to stop junctional bleeding on the battlefield.

Conditions

Interventions

DEVICE

CRoC

Use of Combat Ready Clamp (CRoC)

DEVICE

AAJT

Use of Abdominal Aortic and Junctional Tourniquet (AAJT)

DEVICE

JETT

Use of Junctional Emergency Treatment Tool (JETT)

DEVICE

SJT

Use of SAM Junctional Tourniquet (SJT)

Sponsors & Collaborators

  • United States Army Institute of Surgical Research

    lead FED

Principal Investigators

  • John F Kragh, MD · United States Army Institute of Surgical Research

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01965561 on ClinicalTrials.gov